Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 24, 2026
06:00 PM - 07:00 PM ET
The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
September 29, 2026
12:00 PM - 01:00 PM EDT
Antibody-Drug Conjugates for NSCLC: How They Work and Who’s a Candidate
Laura Alder, MD
Key Questions Shaping Antibody-Drug Conjugate Use in NSCLC
Integrating Molecular Testing into NSCLC Care
Geoffrey Oxnard, MD
A Patient-First Approach to Smoking Cessation and Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
Smarter Screening for Non-Small Cell Lung Cancer
Jobelle Baldonado, MD
Innovations Shaping the Future of Antibody-Drug Conjugates in NSCLC
Christine Bestvina, MD
Improving Adherence and Toxicity Monitoring in NSCLC Care
Raghava Reddy Induru, MD
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Alexandria May, PharmD, BCPS
Shannon Raber, MS, CPNP, RN
Bridget Archambault, MSN, CPNP
A New Era of Hope in Non-Small Cell Lung Cancer Care
The Importance of Multidisciplinary Coordination in NSCLC Care
Tobacco-Related Stigma as a Barrier to Lung Cancer Screening
The Evolving Role of Antibody-Drug Conjugates in NSCLC Care
Emerging Biomarker Research for NSCLC Antibody-Drug Conjugates
Managing Antibody-Drug Conjugate Toxicities in NSCLC Care
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.